<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p><span ><strong>Chronic Bronchitis</strong></span></p><p style="text-align:justify;"><span >This&nbsp;is&nbsp;chronic&nbsp;inflammation&nbsp;of&nbsp;the&nbsp;bronchial mucosa&nbsp;due&nbsp;to&nbsp;irritants such as tobacco smoke. It occurs after the age of 40 years and is part of the syndrome of chronic obstructive pulmonary disease (COPD). There is progressive&nbsp;worsening with&nbsp;age,&nbsp;eventually&nbsp;resulting&nbsp;in&nbsp;chronic respiratory failure. It is aggravated by recurrent viral and bacterial&nbsp;infections.</span></p><p style="text-align:justify;"><span >Oxygen therapy in these patients must be given with caution to prevent carbon dioxide retention due to depression of respiration. High flow rates remove the central hypoxic drive that maintains respiratory effort and can be harmful.</span></p><h3>CAUSES</h3><p>•&nbsp; Cigarette&nbsp;smoking</p><p>•&nbsp; Industrial&nbsp;dust</p><p>•&nbsp; Chemical&nbsp;irritants</p><p>•&nbsp; Inhaled&nbsp;smoke&nbsp;from&nbsp;use&nbsp;of&nbsp;biomass fuels&nbsp;(eg.&nbsp;charcoal,&nbsp;wood)</p><p>&nbsp;</p><h3>SYMPTOMS</h3><ul><li>Shortness of breath, particularly on&nbsp;exertion</li><li>Wheeze</li><li>Fever</li><li>Cough with production of sputum for most of the year</li><li>Infective exacerbation associated with increased quantity of thick purulent sputum</li></ul><h3>SIGNS</h3><ul><li>May be none</li><li>Barrel chest</li><li>Pursed lip breathing</li><li>Clubbing</li><li>Cyanosis</li><li>Increased respiratory rate</li><li>Use of assessory muscles i.e. neck and/or abdominal muscles, for&nbsp;breathing</li><li>Hyperresonance on percussion and loss of cardiac&nbsp;dullness</li><li>Wheeze or rhonchi</li><li>Reduced Peak Expiratory Flow Rate&nbsp;(PEFR)</li></ul><h3>INVESTIGATIONS</h3><ul><li>FBC</li><li>Spirometry,&nbsp;shows reduced lung volumes, particularly FEV1 which is not reversed post-bronchodilator&nbsp;administration</li><li>Chest X-ray</li><li>Sputum culture and gram stain</li></ul><h3>TREATMENT</h3><p><strong>Treatment objectives</strong></p><ul><li>To&nbsp;minimise or stop&nbsp;cough</li><li>To&nbsp;prevent or minimise wheeze and shortness of&nbsp;breath</li><li>To&nbsp;reduce quantity of sputum&nbsp;produced</li><li>To&nbsp;prevent infective exacerbations</li></ul><h3>Non-pharmacological treatment</h3><ul><li>Smoking cessation</li><li>Physical exercise</li><li>Good nutrition</li><li>Use of face mask in high risk occupations</li></ul><h3>Pharmacological treatment</h3><p><span ><strong>A. Stable chronic&nbsp;bronchitis</strong></span></p><p><span ><strong>Evidence Rating: [B]</strong></span></p><ul><li>Salbutamol, inhaled, (via&nbsp;pMDI)</li></ul><p><strong><u>Adults</u></strong></p><p>100 microgram (2 puffs) 4-6 hourly as required</p><p><strong><u>Children</u> (by nebulisation)</strong></p><p>2.5-5 mg 4-6 hourly as required</p><h3>And</h3><ul><li>Tiotropium, inhaled (dry powder&nbsp;inhaler),</li></ul><p><strong><u>Adults</u></strong></p><p>18 microgram (2 puffs) daily</p><p><strong><u>Children</u></strong></p><p>&gt; &nbsp;12&nbsp;years;&nbsp;&nbsp;18 microgram (2 puffs)&nbsp;daily</p><p>&lt;&nbsp;12&nbsp;years;&nbsp;&nbsp;not&nbsp;recommended</p><h3>And</h3><ul><li>Fluticasone/salmeterol, inhaled (via accuhaler or&nbsp;pMDI),</li></ul><p><strong><u>Adults</u></strong></p><p>100/50 microgram or 250/50 microgram or 500/50 microgram, 1 puff 12 hourly</p><p><strong><u>Children</u></strong></p><p>4-12&nbsp;years;&nbsp;&nbsp;100/50 microgram, 1 puff 12&nbsp;hourly</p><p>&lt;&nbsp;4&nbsp;years;&nbsp;&nbsp;&nbsp; safety not&nbsp;established</p><h3>Or</h3><ul><li>Budesonide/formoterol, inhaled (via accuhaler or&nbsp;pMDI),</li></ul><p><strong><u>Adults</u></strong></p><p>160/4.5 microgram 1-2 puffs 12 hourly</p><p><strong><u>Children</u></strong></p><p>&gt;12&nbsp;years;&nbsp;&nbsp;160/4.5 microgram 1-2 puffs 12&nbsp;hourly</p><p>&lt;12&nbsp;years;&nbsp;&nbsp;&nbsp;efficacy not&nbsp;established</p><p><span ><strong>B. Chronic bronchitis with infective&nbsp;exacerbation</strong></span></p><p><span ><strong>Evidence Rating: [C]</strong></span></p><ul><li>Oxygen</li></ul><p>By nasal prongs, 2-6 L/min</p><h3>Or</h3><p>Face mask, 4-8 L/min</p><h3>Or</h3><p>Non-rebreather mask, 10-15 L/min</p><h3>And</h3><ul><li>Salbutamol,&nbsp;nebulised,</li></ul><p><strong><u>Adults</u></strong></p><p>2.5-5 mg repeated initially after 15-30 minutes, then every 2-4 hours until improved</p><p><strong><u>Children</u></strong></p><p>2.5-5 mg 4-6 hourly</p><h3>And</h3><ul><li>Ipratropium bromide,&nbsp;nebulised,</li></ul><p><strong><u>Adults</u></strong></p><p>500 microgram 4-6 hourly, until improved</p><p><strong><u>Children</u></strong></p><p>6-12&nbsp;years;250 microgram 4-6&nbsp;hourly</p><p>1-5&nbsp;years;&nbsp;&nbsp;&nbsp;125 microgram 4-6&nbsp;hourly (max. dose for children 1 mg/24&nbsp;hours)</p><h3>And</h3><ul><li>Amoxicillin (Amoxycillin),&nbsp;oral,</li></ul><p><strong><u>Adults</u></strong></p><p>500 mg 8 hourly for 7-14 days</p><p><strong><u>Children</u></strong></p><p>6-12&nbsp;years;250 mg 8 hourly for 7-14&nbsp;days</p><p>1-5&nbsp;years;125 mg 8 hourly for 7-14&nbsp;days</p><p>&lt;1&nbsp;year;&nbsp;62.5 mg 8 hourly for 7-14&nbsp;days</p><h3>Or</h3><ul><li>Erythromycin,&nbsp;oral,</li></ul><p><strong><u>Adults</u></strong></p><p>500 mg 6 hourly for 7-14 days</p><p><strong><u>Children</u></strong></p><p>8-18&nbsp;years;&nbsp;&nbsp;&nbsp;250-500 mg 6 hourly 7-14&nbsp;days</p><p>2-8&nbsp;years;&nbsp;&nbsp;&nbsp;250 mg 6 hourly 7-14&nbsp;days</p><p>6&nbsp;months-2&nbsp;years;&nbsp;&nbsp;&nbsp;125 mg 6 hourly 7-14&nbsp;days</p><h3>Or</h3><ul><li>Azithromycin,&nbsp;oral,</li></ul><p><strong><u>Adult</u></strong></p><p>500 mg daily for 6 days</p><p><strong><u>Children</u></strong></p><p>10 mg/kg daily for 6 days</p><h3>Or</h3><ul><li>Amoxicillin + Clavulanic Acid,&nbsp;oral,</li></ul><p><u>Adults</u></p><p>1 g 12 hourly for 7-10 days</p><p><strong><u>Children</u></strong></p><ul><li>12&nbsp;years;&nbsp; One 500/125 tablet 12 hourly for 7-10&nbsp;days</li><li>4-12&nbsp;years;&nbsp; 5&nbsp;ml&nbsp;of&nbsp;400/57&nbsp;suspension&nbsp;12&nbsp;hourly&nbsp;for&nbsp;7-10&nbsp;days</li><li>1-4&nbsp;years;&nbsp;&nbsp;&nbsp; 5&nbsp;ml&nbsp;of&nbsp;200/28&nbsp;suspension&nbsp;12&nbsp;hourly&nbsp;for&nbsp;7-10&nbsp;days</li><li>3 months-1 year; 20 mg/kg (of amoxicillin) 12 hourly for 7-10 days</li><li>&lt; 3 months; 15 mg/kg (of amoxicillin) 12 hourly for 7-10 days</li></ul><h3>And</h3><ul><li>Prednisolone,&nbsp;oral,</li></ul><p><strong><u>Adults</u></strong></p><p>30-40 mg for 7 days</p><h3>Then</h3><p>20 mg daily for 5 days, 10 mg daily for 5 days, 5 mg daily for 5 days. Tail down over 2-3 weeks and stop.</p><p><strong><u>Children</u></strong></p><p>1-2 mg/kg for 3-5 days. Tail down over 2-3 weeks and stop.</p><h3>And</h3><ul><li>Acetylcysteine,&nbsp;oral,</li></ul><p style="margin-left:0in;text-align:right;"><u>Adul</u></p><p>10 ml 8 hourly for 5-7 days<u> Children</u> (paediatric formulation) 5-10 ml 8 hourly for 5-7 days</p><h3>Or</h3><p>•&nbsp; Carbocysteine,&nbsp;oral,</p><p><strong><u>Adult</u></strong></p><p>500-750 mg 6-8 hourly</p><p><strong><u>Children</u></strong></p><p>2-5&nbsp;years;&nbsp;&nbsp;&nbsp;62.5-125 mg 6 hourly</p><p>&lt;&nbsp;2&nbsp;years;&nbsp;&nbsp;&nbsp;not&nbsp;recommended</p><h3>REFERRAL CRITERIA</h3><p style="text-align:justify;"><span >Refer&nbsp;all patients not improving on initial management, with acute exacerbation,&nbsp;recurrent&nbsp;infective exacerbations&nbsp;or&nbsp;rapidly deteriorating&nbsp;to a&nbsp;specialist.</span></p>
</body>
</html>
